141 related articles for article (PubMed ID: 32113723)
1. Commentary: How to "spot" a leopard: It's in the genes.
Lazar JF
J Thorac Cardiovasc Surg; 2020 Aug; 160(2):e82-e83. PubMed ID: 32113723
[No Abstract] [Full Text] [Related]
2. Cross-over-it's a feature, not a bug.
Engelsberg A
Ann Oncol; 2015 Sep; 26(9):2000-2002. PubMed ID: 26078468
[TBL] [Abstract][Full Text] [Related]
3. Five-gene signature in non-small-cell lung cancer.
Quintás-Cardama A; Gibbons DL
N Engl J Med; 2007 Apr; 356(15):1582-3; author reply 1583. PubMed ID: 17436429
[No Abstract] [Full Text] [Related]
4. Invited commentary.
Antonoff M
Ann Thorac Surg; 2015 Apr; 99(4):1148. PubMed ID: 25841807
[No Abstract] [Full Text] [Related]
5. Point: should epidermal growth factor receptor mutations be routinely tested for in patients with lung cancer? Yes.
Sterman DH
Chest; 2013 Mar; 143(3):597-600. PubMed ID: 23460149
[No Abstract] [Full Text] [Related]
6. Invited commentary.
Lee HS; Zo JI
Ann Thorac Surg; 2012 May; 93(5):1613. PubMed ID: 22541191
[No Abstract] [Full Text] [Related]
7. Staging and prognosis in lung cancer: making the complex accessible.
Langer CJ
Cancer Treat Res; 2001; 105():53-94. PubMed ID: 11224997
[No Abstract] [Full Text] [Related]
8. Invited commentary.
Antonoff MB
Ann Thorac Surg; 2013 Sep; 96(3):968. PubMed ID: 23992693
[No Abstract] [Full Text] [Related]
9. Quality of life: it's never too late.
Steer CB; Marx GM; Galani E; Harper PG; Khayat D
J Clin Oncol; 2002 Jul; 20(13):2915-7. PubMed ID: 12089218
[No Abstract] [Full Text] [Related]
10. Targeted RNA Sequencing in Non-Small Cell Lung Cancer.
Ritterhouse LL
J Mol Diagn; 2019 Mar; 21(2):183-185. PubMed ID: 30664939
[TBL] [Abstract][Full Text] [Related]
11. Invited commentary.
Antonoff MB
Ann Thorac Surg; 2015 May; 99(5):1754. PubMed ID: 25952203
[No Abstract] [Full Text] [Related]
12. [Mutation analysis of p16 gene in non-small cell lung carcinomas].
Fu S; Wang B; Huang C; Liu Q; Zhang G; Li P
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 1999 Oct; 16(5):293-5. PubMed ID: 10514534
[TBL] [Abstract][Full Text] [Related]
13. From bench to bedside and back again?
CMAJ; 2004 Jun; 170(12):1765, 1767. PubMed ID: 15184306
[No Abstract] [Full Text] [Related]
14. Novel agents in the treatment of lung cancer: conference summary statement.
Lynch TJ; Adjei AA; Bunn PA; DuBois RN; Gandara DR; Giaccone G; Govindan R; Herbst RS; Johnson BE; Khuri FR; Perez-Soler R; Rosell R; Rowinsky EK; Sandler AB; Scagliotti GV; Schiller JH; Shapiro GI; Socinski MA; Hart CS
Clin Cancer Res; 2004 Jun; 10(12 Pt 2):4199s-4204s. PubMed ID: 15217958
[No Abstract] [Full Text] [Related]
15. [Progress in Tissue Specimens Alternative for the Driver Genes Testing of Non-small Cell Lung Cancer].
Sun Y; Song Z
Zhongguo Fei Ai Za Zhi; 2015 Jun; 18(6):387-90. PubMed ID: 26104897
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA expression and outcome in resected NSCLC--letter.
Kageyama S; Takagi Y; Sawada T; Kageyama-Yahara N; Shibuya M
Cancer Res; 2011 Aug; 71(15):5357; author reply 5358-9. PubMed ID: 21791642
[No Abstract] [Full Text] [Related]
17. Study supports routine lung tumor genotyping.
Cancer Discov; 2014 Aug; 4(8):862-3. PubMed ID: 25092729
[No Abstract] [Full Text] [Related]
18. A innovative prognostic symbol based on neutrophil extracellular traps (NETs)-related lncRNA signature in non-small-cell lung cancer.
Fang C; Liu F; Wang Y; Yuan S; Chen R; Qiu X; Qian X; Zhang X; Xiao Z; Wang Q; Fu B; Li Y
Aging (Albany NY); 2021 Jul; 13(13):17864-17879. PubMed ID: 34257164
[TBL] [Abstract][Full Text] [Related]
19. Prevalence and breakdown of EGFR exon 20 driver mutations in routine NHS lung cancer diagnostic testing.
Moore DA; Balbi KJ; Poskitt B; Bennett P
J Clin Pathol; 2022 Mar; 75(3):209-210. PubMed ID: 34168072
[No Abstract] [Full Text] [Related]
20. If it's not CK5/6 positive, TTF-1 negative it's not a squamous cell carcinoma of lung.
Downey P; Cummins R; Moran M; Gulmann C
APMIS; 2008 Jun; 116(6):526-9. PubMed ID: 18754327
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
